Alignment Healthcare, Inc. ALHC
We take great care to ensure that the data presented and summarized in this overview for Alignment Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ALHC
View all-
General Atlantic LLC New York, NY61MShares$1.02 Billion24.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$164 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.65MShares$145 Million0.06% of portfolio
-
Black Rock Inc. New York, NY8.19MShares$137 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.44MShares$125 Million0.02% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY7.3MShares$122 Million2.03% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL4.95MShares$82.9 Million0.96% of portfolio
-
Durable Capital Partners LP Bethesda, MD4.59MShares$76.8 Million0.45% of portfolio
-
8 Knots Management, LLC Dallas, TX3.66MShares$61.2 Million4.65% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.39MShares$56.7 Million0.02% of portfolio
Latest Institutional Activity in ALHC
Top Purchases
Top Sells
About ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Insider Transactions at ALHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,734
-4.99%
|
$454,478
$17.22 P/Share
|
|
Mar 19
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
SELL
Open market or private sale
|
Direct |
6,694
-1.31%
|
$107,104
$16.53 P/Share
|
|
Mar 19
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,632
-1.66%
|
$122,112
$16.53 P/Share
|
|
Mar 19
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
16,535
-0.35%
|
$264,560
$16.53 P/Share
|
|
Mar 19
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,266
-0.76%
|
$132,256
$16.53 P/Share
|
|
Mar 19
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
11,016
-1.23%
|
$176,256
$16.53 P/Share
|
|
Mar 19
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
6,602
-0.48%
|
$105,632
$16.53 P/Share
|
|
Mar 19
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
7,234
-0.51%
|
$115,744
$16.53 P/Share
|
|
Mar 19
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,101
-0.34%
|
$545,616
$16.53 P/Share
|
|
Mar 19
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,432
-0.39%
|
$182,912
$16.53 P/Share
|
|
Mar 18
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,888
-2.07%
|
$78,208
$16.89 P/Share
|
|
Mar 18
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
27,114
-1.12%
|
$433,824
$16.89 P/Share
|
|
Mar 18
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
6,725
-1.47%
|
$107,600
$16.89 P/Share
|
|
Mar 18
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.48%
|
$425,000
$17.01 P/Share
|
|
Mar 18
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,923
-0.55%
|
$62,768
$16.89 P/Share
|
|
Mar 18
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,535
-0.55%
|
$440,560
$16.89 P/Share
|
|
Mar 18
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,815
-0.92%
|
$221,040
$16.89 P/Share
|
|
Mar 17
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.23%
|
$450,000
$15.99 P/Share
|
|
Mar 13
2025
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
General Atlantic (Aln Hlth), L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 6.55M shares |
|---|
| Open market or private sale | 3.79M shares |
|---|---|
| Bona fide gift | 43.6K shares |